AI assistant
Sending…
Monopar Therapeutics — Director's Dealing 2021
Jun 2, 2021
32883_dirs_2021-06-02_6a26922a-d891-43de-a9e7-fbc3514e63e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Monopar Therapeutics (MNPR)
CIK: 0001645469
Period of Report: 2021-06-01
Reporting Person: Cittadine Andrew (N/A)
More from Monopar Therapeutics
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 1
Annual Report
2026
Mar 27
Director's Dealing
2026
Mar 4
Board/Management Information
2026
Mar 2